Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach
Given the complexity of Parkinson's disease (PD), achieving acceptable diagnostic and prognostic accuracy will require the support of a panel of diverse biomarkers. We used Proximity extension assays to measure a panel of 92 proteins in CSF of 120 newly diagnosed PD patients and 45 control subj...
Saved in:
Published in | Neurobiology of disease Vol. 186; p. 106281 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.10.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Given the complexity of Parkinson's disease (PD), achieving acceptable diagnostic and prognostic accuracy will require the support of a panel of diverse biomarkers. We used Proximity extension assays to measure a panel of 92 proteins in CSF of 120 newly diagnosed PD patients and 45 control subjects without neurological disease. From 75 proteins detectable in the CSF of >90% of the subjects, regularized regression analysis identified four proteins (β-NGF, CD38, tau and NCAN) as downregulated in newly diagnosed PD patients (age at diagnosis 67.2 ± 9.4 years) compared to controls (age 65.4 ± 10.9 years). Higher tau (β −0.82 transformed MMSE points/year, 95% CI −1.37 to −0.27, P = 0.005) was also linked to faster cognitive decline over the first ten years after PD diagnosis. These findings provide insights into multiple aspects of PD pathophysiology and may serve as the foundation for identifying new biomarkers and therapeutic targets.
•Proximity extension assays enable high-throughput, multiplex analysis of proteins•PEA detected 4 neurology-related proteins dysregulated in CSF from patients with PD•β-NGF, CD38, Tau and NCAN were all downregulated in newly diagnosed PD patients•Higher Tau protein was linked to faster cognitive decline in PD•The proteins identified reflect broader biology than do the classic PD biomarkers |
---|---|
AbstractList | Given the complexity of Parkinson's disease (PD), achieving acceptable diagnostic and prognostic accuracy will require the support of a panel of diverse biomarkers. We used Proximity extension assays to measure a panel of 92 proteins in CSF of 120 newly diagnosed PD patients and 45 control subjects without neurological disease. From 75 proteins detectable in the CSF of >90% of the subjects, regularized regression analysis identified four proteins (β-NGF, CD38, tau and NCAN) as downregulated in newly diagnosed PD patients (age at diagnosis 67.2 ± 9.4 years) compared to controls (age 65.4 ± 10.9 years). Higher tau (β −0.82 transformed MMSE points/year, 95% CI −1.37 to −0.27, P = 0.005) was also linked to faster cognitive decline over the first ten years after PD diagnosis. These findings provide insights into multiple aspects of PD pathophysiology and may serve as the foundation for identifying new biomarkers and therapeutic targets. Given the complexity of Parkinson's disease (PD), achieving acceptable diagnostic and prognostic accuracy will require the support of a panel of diverse biomarkers. We used Proximity extension assays to measure a panel of 92 proteins in CSF of 120 newly diagnosed PD patients and 45 control subjects without neurological disease. From 75 proteins detectable in the CSF of >90% of the subjects, regularized regression analysis identified four proteins (β-NGF, CD38, tau and NCAN) as downregulated in newly diagnosed PD patients (age at diagnosis 67.2 ± 9.4 years) compared to controls (age 65.4 ± 10.9 years). Higher tau (β −0.82 transformed MMSE points/year, 95% CI −1.37 to −0.27, P = 0.005) was also linked to faster cognitive decline over the first ten years after PD diagnosis. These findings provide insights into multiple aspects of PD pathophysiology and may serve as the foundation for identifying new biomarkers and therapeutic targets. •Proximity extension assays enable high-throughput, multiplex analysis of proteins•PEA detected 4 neurology-related proteins dysregulated in CSF from patients with PD•β-NGF, CD38, Tau and NCAN were all downregulated in newly diagnosed PD patients•Higher Tau protein was linked to faster cognitive decline in PD•The proteins identified reflect broader biology than do the classic PD biomarkers |
ArticleNumber | 106281 |
Author | Maple-Grødem, Jodi Ushakova, Anastasia Pedersen, Kenn Freddy Alves, Guido Tysnes, Ole-Bjørn Lange, Johannes |
Author_xml | – sequence: 1 givenname: Jodi surname: Maple-Grødem fullname: Maple-Grødem, Jodi email: jodi.maple@uis.no, jodi.maple.grodem@sus.no organization: Centre for Movement Disorders, Centre for Brain Health, Stavanger University Hospital, Stavanger, Norway – sequence: 2 givenname: Anastasia surname: Ushakova fullname: Ushakova, Anastasia email: anastasia.ushakova@sus.no organization: Section of Biostatistics, Department of Research, Stavanger University Hospital, Stavanger, Norway – sequence: 3 givenname: Kenn Freddy surname: Pedersen fullname: Pedersen, Kenn Freddy email: kenn.freddy.pedersen@sus.no organization: Centre for Movement Disorders, Centre for Brain Health, Stavanger University Hospital, Stavanger, Norway – sequence: 4 givenname: Ole-Bjørn surname: Tysnes fullname: Tysnes, Ole-Bjørn email: ole-bjorn.tysnes@helse-bergen.no organization: Department of Neurology, Haukeland University Hospital, Bergen, Norway – sequence: 5 givenname: Guido surname: Alves fullname: Alves, Guido email: guido.alves@sus.no organization: Centre for Movement Disorders, Centre for Brain Health, Stavanger University Hospital, Stavanger, Norway – sequence: 6 givenname: Johannes surname: Lange fullname: Lange, Johannes email: johannes.lange@sus.no organization: Centre for Movement Disorders, Centre for Brain Health, Stavanger University Hospital, Stavanger, Norway |
BookMark | eNp9UU1P3DAQtSqQuiz9Ab3l2Eu2_ogdW5wq-rUSEj2AxM1yJpOtt1l7sbMV_Hu8BDgyF2tG771543dGTkIMSMhnRleMMvV1uwpdv-KUi9IrrtkHsmDUyNpIcXdCFtQoUxuj2EdylvOWUsakaRekW_cYJj94cJOPoYpD1Xu3CTFPHioX-mqf4mvb-bhz6R-mfMT9-V4dsg-bylW7wzj5_YgPR_SEcechV25fGgd_z8np4MaMn17eJbn9-ePm8nd9df1rffntqoZGmKnWA2scGNG0RnQOgAqmhZCNVpSVIXRsoKBQNk5Rzg1XQg6SatSdK1AEsSTrWbePbmv3yRevjzY6b58HMW2sS-WMES1v26YdZCltGtWCbhV20CqgfaepZEXry6xVTrg_YJ7szmfAcXQB4yFbrhXnxVepJWEzFFLMOeHwtppRe8zGbm3Jxh6zsXM2hXMxc7D8x3-PyWbwGAB7nxCmYti_w34C3aCXzw |
CitedBy_id | crossref_primary_10_1016_j_compbiomed_2024_108200 crossref_primary_10_3389_fbioe_2024_1415527 |
Cites_doi | 10.1212/WNL.0000000000000641 10.1136/jnnp.2008.168211 10.1016/j.parkreldis.2015.09.027 10.18637/jss.v067.i01 10.1212/WNL.0000000000002350 10.3389/fnagi.2014.00053 10.1186/s12883-020-1608-8 10.1371/journal.pone.0016917 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 10.1016/j.neulet.2020.135074 10.1016/j.jalz.2018.02.018 10.1002/mds.26578 10.1016/j.parkreldis.2014.12.027 10.1016/S1474-4422(06)70471-9 10.1002/sim.9148 10.1136/jnnp.2007.131045 10.1001/jamaneurol.2020.5257 10.1007/s10072-017-3088-1 10.1002/mds.20213 10.1371/journal.pgen.0030098 10.1186/1471-2105-12-77 10.1371/journal.pone.0095192 10.18637/jss.v033.i01 10.1159/000365637 10.1186/s40478-019-0795-2 10.1038/s41598-021-94345-8 10.1093/nar/gkr424 10.1093/brain/awp245 10.1038/s41531-021-00221-7 10.1212/WNL.0b013e3181fc29c9 10.1016/j.ajhg.2013.05.002 10.1146/annurev-statistics-022513-115638 10.1002/ana.22311 10.1016/0022-3956(75)90026-6 10.1111/j.1532-5415.2005.53221.x 10.1136/jnnp-2018-320151 10.1111/joim.12816 |
ContentType | Journal Article |
Copyright | 2023 The Authors |
Copyright_xml | – notice: 2023 The Authors |
DBID | 6I. AAFTH AAYXX CITATION 7X8 DOA |
DOI | 10.1016/j.nbd.2023.106281 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1095-953X |
EndPage | 106281 |
ExternalDocumentID | oai_doaj_org_article_27747f555589467c876ebc76c0db8051 10_1016_j_nbd_2023_106281 S0969996123002966 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 123 1B1 1P~ 1~. 1~5 4.4 457 4G. 5RE 5VS 6I. 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAIKJ AAKOC AALRI AAOAW AAXLA AAXUO ABBQC ABCQJ ABFRF ABJNI ABMAC ABMZM ABTEW ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADVLN AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DM4 DU5 EBS EFBJH EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU G-Q GBLVA GROUPED_DOAJ HVGLF IHE J1W KOM M41 MO0 MOBAO N9A NCXOZ O-L O9- OAUVE OK1 OP~ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SSH SSN SSZ T5K Z5R ZU3 ~G- .55 .GJ 29N 53G AAQFI AAQXK AAYXX ABFNM ABXDB ADFGL ADMUD ASPBG AVWKF AZFZN CAG CITATION COF EJD FGOYB HZ~ K-O R2- SEW X7M XPP ZGI ZMT 7X8 |
ID | FETCH-LOGICAL-c439t-8f14ac934793bacc031833548601347cb1f0c6e54a602292635f508e8ba031ec3 |
IEDL.DBID | AIKHN |
ISSN | 0969-9961 |
IngestDate | Tue Oct 22 15:10:46 EDT 2024 Sat Oct 05 04:48:47 EDT 2024 Wed Oct 23 14:16:48 EDT 2024 Sat Oct 19 15:54:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Biomarkers Parkinson's disease Proximity extension assay CSF |
Language | English |
License | This is an open access article under the CC BY license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-8f14ac934793bacc031833548601347cb1f0c6e54a602292635f508e8ba031ec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0969996123002966 |
PQID | 2862201333 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_27747f555589467c876ebc76c0db8051 proquest_miscellaneous_2862201333 crossref_primary_10_1016_j_nbd_2023_106281 elsevier_sciencedirect_doi_10_1016_j_nbd_2023_106281 |
PublicationCentury | 2000 |
PublicationDate | 2023-10-01 2023-10-00 20231001 |
PublicationDateYYYYMMDD | 2023-10-01 |
PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Neurobiology of disease |
PublicationYear | 2023 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Shi (bb0185) 2011; 69 Yao (bb0205) 2021; 7 Philipps (bb0160) 2014; 43 Jack (bb0100) 2018; 14 Nasreddine (bb0145) 2005; 53 Assarsson (bb0015) 2014; 9 Edwards (bb0055) 2011; 6 Fahn, Elton (bb0060) 1987 Jia (bb0110) 2020; 732 Alves (bb0010) 2009; 80 Lesnick (bb0130) 2007; 3 Lundberg (bb0140) 2011; 39 Davison (bb0045) 1997 Daniel, Lees (bb0040) 1993; 39 Santaella (bb0175) 2020; 20 Sauerbier (bb0180) 2016; 22 Williams-Gray (bb0200) 2009; 132 Friedman (bb0070) 2010; 33 Hall (bb0080) 2016; 31 Kia (bb0120) 2021; 78 Wei (bb0190) 2013; 92 de Lau, Breteler (bb0050) 2006; 5 Rizzo (bb0165) 2016; 86 Noma (bb0150) 2021; 40 Jankovic (bb0105) 2008; 79 Lange (bb0125) 2014; 1 Liu (bb0135) 2015; 21 Baek (bb0020) 2021; 11 Kang (bb0115) 2013; 70 Folstein (bb0065) 1975; 12 Blennow, Zetterberg (bb0030) 2018; 284 Goetz (bb0075) 2004; 19 Dalrymple-Alford (bb0035) 2010; 75 Adler (bb0005) 2014; 83 Whelan (bb0195) 2019; 7 Harrell (bb0085) 1996; 15 Parnetti (bb0155) 2014; 6 Bates (bb0025) 2015; 67 Hu (bb0090) 2017; 38 Jabbari (bb0095) 2019; 90 Robin (bb0170) 2011; 12 Fahn (10.1016/j.nbd.2023.106281_bb0060) 1987 Davison (10.1016/j.nbd.2023.106281_bb0045) 1997 Daniel (10.1016/j.nbd.2023.106281_bb0040) 1993; 39 Edwards (10.1016/j.nbd.2023.106281_bb0055) 2011; 6 Whelan (10.1016/j.nbd.2023.106281_bb0195) 2019; 7 Alves (10.1016/j.nbd.2023.106281_bb0010) 2009; 80 Kang (10.1016/j.nbd.2023.106281_bb0115) 2013; 70 Lange (10.1016/j.nbd.2023.106281_bb0125) 2014; 1 Nasreddine (10.1016/j.nbd.2023.106281_bb0145) 2005; 53 Folstein (10.1016/j.nbd.2023.106281_bb0065) 1975; 12 Jankovic (10.1016/j.nbd.2023.106281_bb0105) 2008; 79 Jia (10.1016/j.nbd.2023.106281_bb0110) 2020; 732 Wei (10.1016/j.nbd.2023.106281_bb0190) 2013; 92 de Lau (10.1016/j.nbd.2023.106281_bb0050) 2006; 5 Rizzo (10.1016/j.nbd.2023.106281_bb0165) 2016; 86 Robin (10.1016/j.nbd.2023.106281_bb0170) 2011; 12 Parnetti (10.1016/j.nbd.2023.106281_bb0155) 2014; 6 Jabbari (10.1016/j.nbd.2023.106281_bb0095) 2019; 90 Blennow (10.1016/j.nbd.2023.106281_bb0030) 2018; 284 Santaella (10.1016/j.nbd.2023.106281_bb0175) 2020; 20 Baek (10.1016/j.nbd.2023.106281_bb0020) 2021; 11 Shi (10.1016/j.nbd.2023.106281_bb0185) 2011; 69 Adler (10.1016/j.nbd.2023.106281_bb0005) 2014; 83 Lundberg (10.1016/j.nbd.2023.106281_bb0140) 2011; 39 Bates (10.1016/j.nbd.2023.106281_bb0025) 2015; 67 Harrell (10.1016/j.nbd.2023.106281_bb0085) 1996; 15 Kia (10.1016/j.nbd.2023.106281_bb0120) 2021; 78 Yao (10.1016/j.nbd.2023.106281_bb0205) 2021; 7 Lesnick (10.1016/j.nbd.2023.106281_bb0130) 2007; 3 Williams-Gray (10.1016/j.nbd.2023.106281_bb0200) 2009; 132 Liu (10.1016/j.nbd.2023.106281_bb0135) 2015; 21 Jack (10.1016/j.nbd.2023.106281_bb0100) 2018; 14 Sauerbier (10.1016/j.nbd.2023.106281_bb0180) 2016; 22 Assarsson (10.1016/j.nbd.2023.106281_bb0015) 2014; 9 Hall (10.1016/j.nbd.2023.106281_bb0080) 2016; 31 Noma (10.1016/j.nbd.2023.106281_bb0150) 2021; 40 Philipps (10.1016/j.nbd.2023.106281_bb0160) 2014; 43 Goetz (10.1016/j.nbd.2023.106281_bb0075) 2004; 19 Dalrymple-Alford (10.1016/j.nbd.2023.106281_bb0035) 2010; 75 Friedman (10.1016/j.nbd.2023.106281_bb0070) 2010; 33 Hu (10.1016/j.nbd.2023.106281_bb0090) 2017; 38 |
References_xml | – volume: 15 start-page: 361 year: 1996 end-page: 387 ident: bb0085 article-title: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors publication-title: Stat. Med. contributor: fullname: Harrell – volume: 90 start-page: 768 year: 2019 end-page: 773 ident: bb0095 article-title: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes publication-title: J. Neurol. Neurosurg. Psychiatry contributor: fullname: Jabbari – volume: 79 start-page: 368 year: 2008 end-page: 376 ident: bb0105 article-title: Parkinson’s disease: clinical features and diagnosis publication-title: J. Neurol. Neurosurg. Psychiatry contributor: fullname: Jankovic – volume: 1 start-page: 279 year: 2014 end-page: 300 ident: bb0125 article-title: Next generation statistical genetics: modeling, penalization, and optimization in high-dimensional data publication-title: Annu. Rev. Stat. Appl. contributor: fullname: Lange – volume: 67 start-page: 1 year: 2015 end-page: 48 ident: bb0025 article-title: Fitting linear mixed-effects models using lme4 publication-title: J. Stat. Softw. contributor: fullname: Bates – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: bb0065 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J. Psychiatr. Res. contributor: fullname: Folstein – year: 1997 ident: bb0045 article-title: Bootstrap Methods and their Applications contributor: fullname: Davison – volume: 14 start-page: 535 year: 2018 end-page: 562 ident: bb0100 article-title: NIA-AA research framework: toward a biological definition of Alzheimer’s disease publication-title: Alzheimers Dement. contributor: fullname: Jack – volume: 6 start-page: 53 year: 2014 ident: bb0155 article-title: Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson’s disease publication-title: Front. Aging Neurosci. contributor: fullname: Parnetti – volume: 78 start-page: 464 year: 2021 end-page: 472 ident: bb0120 article-title: Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets publication-title: JAMA Neurol. contributor: fullname: Kia – volume: 5 start-page: 525 year: 2006 end-page: 535 ident: bb0050 article-title: Epidemiology of Parkinson’s disease publication-title: Lancet Neurol. contributor: fullname: Breteler – volume: 39 start-page: 165 year: 1993 end-page: 172 ident: bb0040 article-title: Parkinson’s disease society Brain Bank, London: overview and research publication-title: J. Neural Transm. Suppl. contributor: fullname: Lees – volume: 33 start-page: 1 year: 2010 end-page: 22 ident: bb0070 article-title: Regularization paths for generalized linear models via coordinate descent publication-title: J. Stat. Softw. contributor: fullname: Friedman – volume: 80 start-page: 851 year: 2009 end-page: 857 ident: bb0010 article-title: Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study publication-title: J. Neurol. Neurosurg. Psychiatry contributor: fullname: Alves – volume: 38 start-page: 1953 year: 2017 end-page: 1961 ident: bb0090 article-title: Changes of cerebrospinal fluid Abeta(42), t-tau, and p-tau in Parkinson’s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis publication-title: Neurol. Sci. contributor: fullname: Hu – volume: 132 start-page: 2958 year: 2009 end-page: 2969 ident: bb0200 article-title: The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort publication-title: Brain. contributor: fullname: Williams-Gray – volume: 39 year: 2011 ident: bb0140 article-title: Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood publication-title: Nucleic Acids Res. contributor: fullname: Lundberg – volume: 19 start-page: 1020 year: 2004 end-page: 1028 ident: bb0075 article-title: Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations publication-title: Mov. Disord. contributor: fullname: Goetz – volume: 732 year: 2020 ident: bb0110 article-title: Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson’s disease publication-title: Neurosci. Lett. contributor: fullname: Jia – volume: 7 start-page: 79 year: 2021 ident: bb0205 article-title: A transcriptome-wide association study identifies susceptibility genes for Parkinson's disease publication-title: NPJ Parkinsons Dis. contributor: fullname: Yao – volume: 22 start-page: S41 year: 2016 end-page: S46 ident: bb0180 article-title: Non motor subtypes and Parkinson’s disease publication-title: Parkinsonism Relat. Disord. contributor: fullname: Sauerbier – volume: 11 start-page: 14820 year: 2021 ident: bb0020 article-title: Temporal trajectory of biofluid markers in Parkinson’s disease publication-title: Sci. Rep. contributor: fullname: Baek – volume: 3 year: 2007 ident: bb0130 article-title: A genomic pathway approach to a complex disease: axon guidance and Parkinson disease publication-title: PLoS Genet. contributor: fullname: Lesnick – volume: 70 start-page: 1277 year: 2013 end-page: 1287 ident: bb0115 article-title: Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease publication-title: JAMA Neurol. contributor: fullname: Kang – volume: 40 start-page: 5691 year: 2021 end-page: 5701 ident: bb0150 article-title: Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap-based optimism correction methods publication-title: Stat. Med. contributor: fullname: Noma – volume: 53 start-page: 695 year: 2005 end-page: 699 ident: bb0145 article-title: The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment publication-title: J. Am. Geriatr. Soc. contributor: fullname: Nasreddine – volume: 86 start-page: 566 year: 2016 end-page: 576 ident: bb0165 article-title: Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis publication-title: Neurology. contributor: fullname: Rizzo – volume: 6 year: 2011 ident: bb0055 article-title: Identifying consensus disease pathways in Parkinson’s disease using an integrative systems biology approach publication-title: PLoS One contributor: fullname: Edwards – volume: 20 start-page: 26 year: 2020 ident: bb0175 article-title: Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms publication-title: BMC Neurol. contributor: fullname: Santaella – volume: 7 start-page: 169 year: 2019 ident: bb0195 article-title: Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease publication-title: Acta Neuropathol. Commun. contributor: fullname: Whelan – volume: 83 start-page: 406 year: 2014 end-page: 412 ident: bb0005 article-title: Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study publication-title: Neurology. contributor: fullname: Adler – volume: 43 start-page: 15 year: 2014 end-page: 25 ident: bb0160 article-title: Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies publication-title: Neuroepidemiology. contributor: fullname: Philipps – volume: 92 start-page: 1008 year: 2013 end-page: 1012 ident: bb0190 article-title: Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease publication-title: Am. J. Hum. Genet. contributor: fullname: Wei – volume: 31 start-page: 898 year: 2016 end-page: 905 ident: bb0080 article-title: Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson’s disease publication-title: Mov. Disord. contributor: fullname: Hall – volume: 9 year: 2014 ident: bb0015 article-title: Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability publication-title: PLoS One contributor: fullname: Assarsson – volume: 12 start-page: 77 year: 2011 ident: bb0170 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinform. contributor: fullname: Robin – volume: 75 start-page: 1717 year: 2010 end-page: 1725 ident: bb0035 article-title: The MoCA: well-suited screen for cognitive impairment in Parkinson disease publication-title: Neurology. contributor: fullname: Dalrymple-Alford – volume: 21 start-page: 271 year: 2015 end-page: 276 ident: bb0135 article-title: CSF tau and tau/Abeta42 predict cognitive decline in Parkinson’s disease publication-title: Parkinsonism Relat. Disord. contributor: fullname: Liu – volume: 284 start-page: 643 year: 2018 end-page: 663 ident: bb0030 article-title: Biomarkers for Alzheimer’s disease: current status and prospects for the future publication-title: J. Intern. Med. contributor: fullname: Zetterberg – start-page: 153 year: 1987 end-page: 163 ident: bb0060 article-title: Unified Parkinson’s disease rating scale publication-title: Recent Developments in Parkinson’s disease. contributor: fullname: Elton – volume: 69 start-page: 570 year: 2011 end-page: 580 ident: bb0185 article-title: Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression publication-title: Ann. Neurol. contributor: fullname: Shi – volume: 83 start-page: 406 year: 2014 ident: 10.1016/j.nbd.2023.106281_bb0005 article-title: Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study publication-title: Neurology. doi: 10.1212/WNL.0000000000000641 contributor: fullname: Adler – volume: 80 start-page: 851 year: 2009 ident: 10.1016/j.nbd.2023.106281_bb0010 article-title: Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.2008.168211 contributor: fullname: Alves – volume: 22 start-page: S41 issue: Suppl. 1 year: 2016 ident: 10.1016/j.nbd.2023.106281_bb0180 article-title: Non motor subtypes and Parkinson’s disease publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2015.09.027 contributor: fullname: Sauerbier – volume: 67 start-page: 1 year: 2015 ident: 10.1016/j.nbd.2023.106281_bb0025 article-title: Fitting linear mixed-effects models using lme4 publication-title: J. Stat. Softw. doi: 10.18637/jss.v067.i01 contributor: fullname: Bates – volume: 86 start-page: 566 year: 2016 ident: 10.1016/j.nbd.2023.106281_bb0165 article-title: Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis publication-title: Neurology. doi: 10.1212/WNL.0000000000002350 contributor: fullname: Rizzo – volume: 6 start-page: 53 year: 2014 ident: 10.1016/j.nbd.2023.106281_bb0155 article-title: Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson’s disease publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2014.00053 contributor: fullname: Parnetti – volume: 20 start-page: 26 year: 2020 ident: 10.1016/j.nbd.2023.106281_bb0175 article-title: Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms publication-title: BMC Neurol. doi: 10.1186/s12883-020-1608-8 contributor: fullname: Santaella – volume: 6 year: 2011 ident: 10.1016/j.nbd.2023.106281_bb0055 article-title: Identifying consensus disease pathways in Parkinson’s disease using an integrative systems biology approach publication-title: PLoS One doi: 10.1371/journal.pone.0016917 contributor: fullname: Edwards – volume: 15 start-page: 361 year: 1996 ident: 10.1016/j.nbd.2023.106281_bb0085 article-title: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors publication-title: Stat. Med. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 contributor: fullname: Harrell – volume: 732 year: 2020 ident: 10.1016/j.nbd.2023.106281_bb0110 article-title: Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson’s disease publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2020.135074 contributor: fullname: Jia – volume: 14 start-page: 535 year: 2018 ident: 10.1016/j.nbd.2023.106281_bb0100 article-title: NIA-AA research framework: toward a biological definition of Alzheimer’s disease publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2018.02.018 contributor: fullname: Jack – volume: 31 start-page: 898 year: 2016 ident: 10.1016/j.nbd.2023.106281_bb0080 article-title: Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson’s disease publication-title: Mov. Disord. doi: 10.1002/mds.26578 contributor: fullname: Hall – volume: 39 start-page: 165 year: 1993 ident: 10.1016/j.nbd.2023.106281_bb0040 article-title: Parkinson’s disease society Brain Bank, London: overview and research publication-title: J. Neural Transm. Suppl. contributor: fullname: Daniel – volume: 21 start-page: 271 year: 2015 ident: 10.1016/j.nbd.2023.106281_bb0135 article-title: CSF tau and tau/Abeta42 predict cognitive decline in Parkinson’s disease publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2014.12.027 contributor: fullname: Liu – volume: 5 start-page: 525 year: 2006 ident: 10.1016/j.nbd.2023.106281_bb0050 article-title: Epidemiology of Parkinson’s disease publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(06)70471-9 contributor: fullname: de Lau – volume: 40 start-page: 5691 year: 2021 ident: 10.1016/j.nbd.2023.106281_bb0150 article-title: Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap-based optimism correction methods publication-title: Stat. Med. doi: 10.1002/sim.9148 contributor: fullname: Noma – volume: 79 start-page: 368 year: 2008 ident: 10.1016/j.nbd.2023.106281_bb0105 article-title: Parkinson’s disease: clinical features and diagnosis publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.2007.131045 contributor: fullname: Jankovic – volume: 78 start-page: 464 year: 2021 ident: 10.1016/j.nbd.2023.106281_bb0120 article-title: Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2020.5257 contributor: fullname: Kia – year: 1997 ident: 10.1016/j.nbd.2023.106281_bb0045 contributor: fullname: Davison – volume: 38 start-page: 1953 year: 2017 ident: 10.1016/j.nbd.2023.106281_bb0090 article-title: Changes of cerebrospinal fluid Abeta(42), t-tau, and p-tau in Parkinson’s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis publication-title: Neurol. Sci. doi: 10.1007/s10072-017-3088-1 contributor: fullname: Hu – volume: 19 start-page: 1020 year: 2004 ident: 10.1016/j.nbd.2023.106281_bb0075 article-title: Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations publication-title: Mov. Disord. doi: 10.1002/mds.20213 contributor: fullname: Goetz – volume: 3 year: 2007 ident: 10.1016/j.nbd.2023.106281_bb0130 article-title: A genomic pathway approach to a complex disease: axon guidance and Parkinson disease publication-title: PLoS Genet. doi: 10.1371/journal.pgen.0030098 contributor: fullname: Lesnick – volume: 12 start-page: 77 year: 2011 ident: 10.1016/j.nbd.2023.106281_bb0170 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinform. doi: 10.1186/1471-2105-12-77 contributor: fullname: Robin – volume: 9 year: 2014 ident: 10.1016/j.nbd.2023.106281_bb0015 article-title: Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability publication-title: PLoS One doi: 10.1371/journal.pone.0095192 contributor: fullname: Assarsson – volume: 33 start-page: 1 year: 2010 ident: 10.1016/j.nbd.2023.106281_bb0070 article-title: Regularization paths for generalized linear models via coordinate descent publication-title: J. Stat. Softw. doi: 10.18637/jss.v033.i01 contributor: fullname: Friedman – volume: 43 start-page: 15 year: 2014 ident: 10.1016/j.nbd.2023.106281_bb0160 article-title: Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies publication-title: Neuroepidemiology. doi: 10.1159/000365637 contributor: fullname: Philipps – volume: 7 start-page: 169 year: 2019 ident: 10.1016/j.nbd.2023.106281_bb0195 article-title: Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease publication-title: Acta Neuropathol. Commun. doi: 10.1186/s40478-019-0795-2 contributor: fullname: Whelan – volume: 11 start-page: 14820 year: 2021 ident: 10.1016/j.nbd.2023.106281_bb0020 article-title: Temporal trajectory of biofluid markers in Parkinson’s disease publication-title: Sci. Rep. doi: 10.1038/s41598-021-94345-8 contributor: fullname: Baek – volume: 39 year: 2011 ident: 10.1016/j.nbd.2023.106281_bb0140 article-title: Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkr424 contributor: fullname: Lundberg – volume: 132 start-page: 2958 year: 2009 ident: 10.1016/j.nbd.2023.106281_bb0200 article-title: The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort publication-title: Brain. doi: 10.1093/brain/awp245 contributor: fullname: Williams-Gray – volume: 7 start-page: 79 year: 2021 ident: 10.1016/j.nbd.2023.106281_bb0205 article-title: A transcriptome-wide association study identifies susceptibility genes for Parkinson's disease publication-title: NPJ Parkinsons Dis. doi: 10.1038/s41531-021-00221-7 contributor: fullname: Yao – volume: 75 start-page: 1717 year: 2010 ident: 10.1016/j.nbd.2023.106281_bb0035 article-title: The MoCA: well-suited screen for cognitive impairment in Parkinson disease publication-title: Neurology. doi: 10.1212/WNL.0b013e3181fc29c9 contributor: fullname: Dalrymple-Alford – volume: 92 start-page: 1008 year: 2013 ident: 10.1016/j.nbd.2023.106281_bb0190 article-title: Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2013.05.002 contributor: fullname: Wei – start-page: 153 year: 1987 ident: 10.1016/j.nbd.2023.106281_bb0060 article-title: Unified Parkinson’s disease rating scale contributor: fullname: Fahn – volume: 1 start-page: 279 year: 2014 ident: 10.1016/j.nbd.2023.106281_bb0125 article-title: Next generation statistical genetics: modeling, penalization, and optimization in high-dimensional data publication-title: Annu. Rev. Stat. Appl. doi: 10.1146/annurev-statistics-022513-115638 contributor: fullname: Lange – volume: 69 start-page: 570 year: 2011 ident: 10.1016/j.nbd.2023.106281_bb0185 article-title: Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression publication-title: Ann. Neurol. doi: 10.1002/ana.22311 contributor: fullname: Shi – volume: 12 start-page: 189 year: 1975 ident: 10.1016/j.nbd.2023.106281_bb0065 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J. Psychiatr. Res. doi: 10.1016/0022-3956(75)90026-6 contributor: fullname: Folstein – volume: 53 start-page: 695 year: 2005 ident: 10.1016/j.nbd.2023.106281_bb0145 article-title: The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment publication-title: J. Am. Geriatr. Soc. doi: 10.1111/j.1532-5415.2005.53221.x contributor: fullname: Nasreddine – volume: 90 start-page: 768 year: 2019 ident: 10.1016/j.nbd.2023.106281_bb0095 article-title: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2018-320151 contributor: fullname: Jabbari – volume: 284 start-page: 643 year: 2018 ident: 10.1016/j.nbd.2023.106281_bb0030 article-title: Biomarkers for Alzheimer’s disease: current status and prospects for the future publication-title: J. Intern. Med. doi: 10.1111/joim.12816 contributor: fullname: Blennow – volume: 70 start-page: 1277 year: 2013 ident: 10.1016/j.nbd.2023.106281_bb0115 article-title: Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease publication-title: JAMA Neurol. contributor: fullname: Kang |
SSID | ssj0011597 |
Score | 2.478399 |
Snippet | Given the complexity of Parkinson's disease (PD), achieving acceptable diagnostic and prognostic accuracy will require the support of a panel of diverse... |
SourceID | doaj proquest crossref elsevier |
SourceType | Open Website Aggregation Database Publisher |
StartPage | 106281 |
SubjectTerms | Biomarkers CSF Parkinson's disease Proximity extension assay |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yB_Eiuqu4voggHoRiX2na4_piEVY8uLC3kKSJKNiVfYD-e2eSRlwPevGYkiZhpul8Sb75QshpbTNTF1kcyVxy3K1ikUytgRnPLWcQvxKnWzC6L4bj_G7CJt-u-kJOmJcH9oa7SAGfcMtQlgpvg9cwe43SvNBxrcqY-YVPwsJiqj0_gCDNwxmmY3M1CmVB0wzKRVomK1HIifWvBKMfv2UXa263yGYLEunAD26brJmmS3qDBhbIrx_0jDraptsP75L1UXs63iPKZ93adhuOTi2tPZMO2qGyqSmysdoi5t0jNWc2x3oP1xQZ8E9U0kAxfKdOwwGzluc0SI_vkPHtzePVMGrvUIg0QI1FVNokl7py-aJKau3mcMbw6ilMItUqsbEuDMtlAdG8QmkaC5jNlEpCVaOzXdJppo3ZI9SCwRPF4WXDc1NpVRsN4IzFaV3zIq_65DzYVLx5qQwROGQvAhwg0AHCO6BPLtHqXxVR5do9AN-L1vfiL9_3SR58JlrA4IEANPX8W98nwb8CJhOekMjGTJdzkcL6DhBRlmX7_zG-A7KB3Xru3yHpLGZLcwQYZqGO3ef6Ceer7HQ priority: 102 providerName: Directory of Open Access Journals |
Title | Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach |
URI | https://dx.doi.org/10.1016/j.nbd.2023.106281 https://search.proquest.com/docview/2862201333 https://doaj.org/article/27747f555589467c876ebc76c0db8051 |
Volume | 186 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS_QwEB50hRcv4sf74vqxRBAPQt_dtmm6Pa5frIoiqOAtJGkiK9iV3RX04m93Jk2F9eDBY0qSlkwz8zTzzFOA_dKlthRpL1Jc5XRalUUqcRZ3fO7yDONX7HULrq7F8J5fPGQPC3Dc1MIQrTL4_tqne28drnTDanZfRqPuLYJvQuvoeim1JMQiLGE44rwFS4Pzy-H1VzIBI7avmsb-EQ1okpue5lVp0gtNUmyLpB_PhSev4j8Xpb75ax-EzlZhJaBHNqgfcA0WbLUOG4MKv5yf39kB83xOf1C-Dn-uQtp8A3RdjuvC-RwbO1bWFDuch6mqZETTCk0qyCfOzmRK_W5OGFHjH5liDffwjXlxBypnnrJGk_wv3J-d3h0Po_BzhcggBplFfRdzZQpfSKqVMX5zpxn9k4qqS42OXc8Im3ElMMwXpFnjEMzZvlbY1Zr0H7SqcWU3gblSI_jNcbDNuS2MLq1B1Jb1krLMBS_acNisqXypNTRkQy57kmgASQaQtQHacESr_tWR5K_9hfHkUQb7ywRBa-4y0ior0NMbdOlWm1yYHj4Kupk28MZmcu5twqlGP917r7GvxF1GqRNV2fHrVCb44YdQKU3Trd9NvQ3L1KppgDvQmk1e7S7CmZnuwOL_j7gTXtqOPxT4BEeR8qM |
link.rule.ids | 315,786,790,870,2115,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50BfUiPnF9RhAPQt3dPtLtcX2xPlYEFbyFJE2WFezK7gp68bc7k6bCevDgse00LZlm5mvyzReAw9xGJudRM5CxTGm2KglkaA2O-NSmCeavltMt6N3x7lN8_Zw8z8BZVQtDtEof-8uY7qK1P9Pwvdl4GwwaDwi-Ca1j6KWlJc5nYY7QAPG6Tr5-eB6IeNwOK2QdkHm1tOlIXoUitdAwwmMetltTyclp-E_lqF_R2qWgy2VY8tiRdcrXW4EZU6zCWqfA_-bXT3bEHJvTTZOvwnzPL5qvgSqLca2fnWNDy_KSYIftMFnkjEha_pDK8YmxMxqT3f05I2J8n0lWMQ8_mJN2oGLmMasUydfh6fLi8awb-K0VAo0IZBK0bSuWOnNlpEpq7YZ2lNCOVFRbqlXLNjU3SSw5JvmMFGssQjnTVhJNjY42oFYMC7MJzOYKoW-KN5s0NplWudGI2ZJmmOcpj7M6HFd9Kt5KBQ1RUcteBDpAkANE6YA6nFKv_xiS-LU7MRz1hfe-CBGypjYhpbIM47zGgG6UTrlu4qtgkKlDXPlMTH1L2NTgr2cfVP4VOMZo4UQWZvg-FiH-9iFQiqJo639N78NC97F3K26v7m62YZGulITAHahNRu9mF4HNRO25D_cbvbXygw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+diagnostic+and+prognostic+biomarkers+of+PD+using+a+multiplex+proteomics+approach&rft.jtitle=Neurobiology+of+disease&rft.au=Maple-Gr%C3%B8dem%2C+Jodi&rft.au=Ushakova%2C+Anastasia&rft.au=Pedersen%2C+Kenn+Freddy&rft.au=Tysnes%2C+Ole-Bj%C3%B8rn&rft.date=2023-10-01&rft.pub=Elsevier+Inc&rft.issn=0969-9961&rft.volume=186&rft_id=info:doi/10.1016%2Fj.nbd.2023.106281&rft.externalDocID=S0969996123002966 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-9961&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-9961&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-9961&client=summon |